Difference between revisions of "Recurrent Genomic Alterations in Pediatric and Adult Central Nervous System Tumors Detected by Chromosomal Microarray"
Jump to navigation
Jump to search
| [unchecked revision] | [unchecked revision] |
| Line 1: | Line 1: | ||
| − | ==Recurrent Genomic Alterations in Pediatric and Adult CNS Detected by Chromosomal Microarray | + | ==Recurrent Genomic Alterations in Pediatric and Adult CNS Detected by Chromosomal Microarray |
| − | Table 1 - Pediatric Central Nervous System Tumors. Table derived from | + | Table 1 - Pediatric Central Nervous System Tumors. Table derived from CGC CNS Workgroup 2018. |
{| class="wikitable" | {| class="wikitable" | ||
|- | |- | ||
| Line 33: | Line 33: | ||
| Generally indolent tumors for which surgical resection can be curative | | Generally indolent tumors for which surgical resection can be curative | ||
| PMID:25461780; PMID:23583981; PMID:11996800 PMID:23609006; PMID:29880043 | | PMID:25461780; PMID:23583981; PMID:11996800 PMID:23609006; PMID:29880043 | ||
| + | |- | ||
| + | |Low grade glioma, WHO grade II | ||
| + | |Diffuse astrocytoma | ||
| + | |No diagnostic aberrations | ||
| + | | '''Rearrangement:''' MYBL1 truncating rearrangements and tandem duplication, FGFR1 rearrangements; '''Mutation:''' FGFR1 | ||
| + | | Anaplastic features associated with decreased progression free survival | ||
| + | | PMID:25664944; PMID:23633565; PMID:26061751 PMID:26824661; PMID:26004297; PMID:25461780 PMID:23583981 | ||
|- | |- | ||
| | | | ||
| + | | Pleomorphic xanthoastrocytoma (PXA) | ||
| + | | Polysomy 3, polysomy 7 observed; '''Loss:''' monosomy 9 / 9p deletion | ||
| + | | '''Mutations:''' BRAF V600E in ~60%; TP53 (5%); '''Loss:''' CDKN2A/CDKN2B | ||
| + | | | ||
| + | | PMID:25461780; PMID:23583981; PMID:16909113; PMID:12484572 | ||
| + | |- | ||
Revision as of 14:15, 15 November 2018
==Recurrent Genomic Alterations in Pediatric and Adult CNS Detected by Chromosomal Microarray
Table 1 - Pediatric Central Nervous System Tumors. Table derived from CGC CNS Workgroup 2018.
| TUMOR | SUBTYPES | BROAD ABERRATIONS (>10Mb) | FOCAL ABERRATIONS (>10Mb) | CLINICAL FEATURES | REFERENCES |
|---|---|---|---|---|---|
| GLIOMAS | |||||
| Low grade glioma, WHO grade I | Pilocytic astrocytoma/pilomyxoid astrocytoma | Some tumors show polysomy 7; other polysomies more common in adult PA | Fusions: KIAA1549-BRAF fusion (via 3'BRAF duplication), other BRAF partners reported; NTRK fusions (rare); FGFR1 fusions (rare); Mutations: BRAF V600E (particularly extra-cerebellar tumors); FGFR1 (midline PA); NF1 (esp. germline), other MAPK pathway mutations Loss: NF1 in optic pathway PA | Classic PA are cerebellar (most commonly associated with BRAF duplication); PA in patients with germline NF1 alterations often develop as optic gliomas;Surgical resection can be curative; PMA generally more aggressive than PA; BRAF fusions and BRAF mutations generally are mutually exclusive | PMID:19016743; PMCID:2761618; PMID:18716556 PMID:25461780 PMID:25664944; PMID:26378811 PMCID:3429698; PMID:23817572; PMID:23583981 PMID:18974108; PMID:23278243; PMID:21274720 |
| Angiocentric glioma | Aberrations involving 6q24-q25 | Fusions: MYB-QKI rearrangement/deletion (classic histology); Rearrangement: MYB alone (atypical histology); Amplification: MYB (atypical histology) | Generally indolent tumors; surgical resection can be curative | PMID:26829751; PMID:23633565; PMID:26778052 PMID:23583981 | |
| Ganglioglioma | Only 30% are abnormal by karyotype Gain: polysomy 7 | Mutations: BRAF V600E in 20-60% of cases (can be concurrent with CDKN2A homozygous deletion); Fusions: KIAA1549-BRAF | Generally indolent tumors for which surgical resection can be curative | PMID:25461780; PMID:23583981; PMID:11996800 PMID:23609006; PMID:29880043 | |
| Low grade glioma, WHO grade II | Diffuse astrocytoma | No diagnostic aberrations | Rearrangement: MYBL1 truncating rearrangements and tandem duplication, FGFR1 rearrangements; Mutation: FGFR1 | Anaplastic features associated with decreased progression free survival | PMID:25664944; PMID:23633565; PMID:26061751 PMID:26824661; PMID:26004297; PMID:25461780 PMID:23583981 |
| Pleomorphic xanthoastrocytoma (PXA) | Polysomy 3, polysomy 7 observed; Loss: monosomy 9 / 9p deletion | Mutations: BRAF V600E in ~60%; TP53 (5%); Loss: CDKN2A/CDKN2B | PMID:25461780; PMID:23583981; PMID:16909113; PMID:12484572 |